media – Page 2 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

The first RAP active temperature-controlled aviation box in China is launched to keep medicines in the “cold chain”

On February 25, temperature control is crucial in the field of aviation cold chain transportation, especially in the transportation of vaccines and biopharmaceuticals. CIMC, headquartered in Shenzhen, announced on the 25th that it had successfully developed the first RAP active temperature-controlled aviation box in China. It not only fills the gap in similar products in China, but also enables “heaven-earth linkage” full-process tracking to ensure that medicines do not lose the “cold chain”. For a long time, Chinese airlines have mainly relied on aviation boxes leased from abroad, which is costly. In 2020, Qingdao CIMC Special Refrigeration Equipment Co., Ltd. (hereinafter referred to as “CIMC Qingdao Refrigerated Special Box”), a subsidiary of CIMC, developed the first RKN active temperature-controlled aviation container in China, breaking the foreign monopoly in one fell swoop. The RKN air box is powered by a battery and uses a refrigeration unit to control the temperature inside ...
- Source: drugdu
- 39
- February 27, 2025
R&D is more difficult and the production process is more complicated.

On February 25, the Hong Kong stock price of CanSino Biologics (06185.HK, share price of HK$37.35, market value of HK$9.2 billion) once soared by more than 15%. On the news front, the company issued an announcement the day before, saying that the adsorbed acellular pertussis (component) Haemophilus influenzae type b (combined)-ACYW135 group meningococcal (combined) combined vaccine (DTcP-Hib-MCV4) has been approved for drug clinical trials. This is a pentavalent vaccine that prevents multiple diseases at the same time. It has three components: the first Asian quadrivalent meningococcal conjugate vaccine “Manhaixin” that has been approved for marketing, the second is the adsorbed acellular diphtheria (component) pertussis combined vaccine for infants and young children in the phase III clinical stage, and the third is the Hib vaccine (Haemophilus influenzae type b vaccine) in the phase I clinical stage. It is worth noting that this is the first domestic pentavalent vaccine to reach the ...
- Source: drugdu
- 37
- February 27, 2025
MEDEXPO Kenya

Organiser：EXPOGROUP Time：May 14th – 16th, 2025 Address：P.O. Box 30746-00100 Harambee Avenue, Nairobi, Kenya. Exhibition hall：Kenyatta International Conference Centre Product range: Medical Equipment: Anesthesia equipment, respiratory equipment, imaging equipment, blood pressure equipment, diagnostic instruments and devices, dialysis equipment, electro (high-frequency) therapy, surgical instruments, EEG machines, ECG (electrocardiograph) equipment and accessories, UV and IR radiation equipment, laboratory supplies, ultrasonic diagnostic equipment, cardiac catheterization equipment, infusion technology equipment, MRI scanning equipment, laser treatment, surgical equipment, etc. Dental Equipment: Dental instruments and equipment, maintenance and repair, filling materials, radiological equipment and products, sterilization systems, dental care products. Optical Equipment: Optometric examination equipment, optical and sunglasses frames, lens frames and manufacturing equipment and accessories, optical instruments and components. Healthcare Products: Medical herbal preparations, food supplements, vitamins and minerals, dietary and nutritional products, personal hygiene products, homeopathic preparations, dermatological preparations, mother and baby care, baby food, fitness equipment, and other healthcare-related products. About MEDEXPO ...
- Source: drugdu
- 38
- February 27, 2025
Technological innovation helps Yuekang Pharmaceutical achieve breakthroughs in new drug research and development

Recently, the National Drug Administration Drug Evaluation Center (CDE) announced that the clinical trial application (IND) for the mRNA vaccine YKYY025 injection for the prevention of respiratory syncytial virus (RSV) submitted by Hangzhou Tianlong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Yuekang Pharmaceutical, has been accepted. Prior to this, this vaccine had been approved for clinical trials by the US FDA at the beginning of this year. “Insight into and meeting clinical needs that have not yet been fully responded to have always been the core orientation and key path for our research and development work.” Yu Weishi, chairman of Yuekang Pharmaceutical Group, said. It is reported that in addition to RSV vaccines, Yuekang Pharmaceutical has obtained overseas clinical approval for a number of innovative drugs. On January 21, Yuekang Pharmaceutical’s independently developed mRNA vaccine YKYY026 injection for the prevention of herpes zoster was officially accepted by CDE. Since it ...
- Source: drugdu
- 37
- February 27, 2025
Pharmaceutical companies connect with DeepSeek to reduce costs, and the cost of accurate error correction of general models is high

DeepSeek is penetrating into various industries. In February 2025, the domestic large model DeepSeek-R1 was fully open source and adapted to multiple fields, and AI medical care also entered a new stage of technology integration and industry reconstruction. Many companies including Aimi Vaccine, Hengrui Medicine, and Zhiyun Health announced that they are combining with AI large models such as DeepSeek. Take the recent announcement of Aimi Vaccine as an example. It stated that as a leading vaccine company in China, the group actively responded to the national “AI+” industrial development strategy and fully deployed access to the DeepSeek large model. However, the financial report of Aimi Vaccine shows that it has faced continuous losses in recent years. To what extent can DeepSeek reduce costs and increase efficiency? Many industry analysts consulted by Blue Whale Finance all said that overall, they are optimistic about the application of AI big models such ...
- Source: drugdu
- 46
- February 27, 2025
Authorized cooperation accelerates the pace of Chaoyong pharmaceutical companies going global

Recently, Shiyao Group announced that its subsidiary Shiyao Jushi has signed an exclusive authorization agreement with Radiance Biopharma for the antibody conjugate drug SYS6005. Since 2025, several pharmaceutical companies, including Xinda Biotechnology and Xiansheng Pharmaceutical, have signed large orders with potential amounts of up to 1 billion US dollars. Industry insiders believe that the overall progress of domestic new drug research and development is commendable, and Chinese pharmaceutical companies with strong research and development capabilities are expected to compete with foreign-funded enterprises in the global market. They are optimistic about the prospects of domestic new drug research and development and going global in 2025. Multiple products achieve overseas authorization According to the announcement from Shiyao Group, Shiyao Giant Stone has agreed to grant Radiance Biopharma exclusive authorization to develop and commercialize SYS6005 in the United States, European Union, United Kingdom, Switzerland, Norway, Iceland, Liechtenstein, Albania, Montenegro, North Macedonia, Serbia, Australia, ...
- Source: drugdu
- 43
- February 26, 2025
11.4 billion, Boston Science has a big move

On February 21, 2025, Boston Scientific (NYSE: BSX) announced that its fully funded subsidiary, American Medical Systems Europe B.V. (“AMS Europe”), has priced a total of 1.5 billion euros (approximately RMB 11.377 billion) in notes (a type of bond issuance). The funds obtained from this issuance, along with the company’s cash on hand, will be used for debt repayment, working capital, and potential future acquisitions. As of February 21st, Boston Scientific’s latest stock price is $104.49 per share, with a total market value of $154 billion, reaching its highest point since going public. 01. Issuing bonds worth billions, PFA’s performance skyrocketed by 172% The notes issued this time consist of two transactions, one with a total principal of 850 million euros and an interest rate of 3.000%, due in 2031; The other principal amount is 650 million euros, with an interest rate of 3.250%, due in 2034. The bill will ...
- Source: drugdu
- 42
- February 26, 2025
9 Medical Devices Enter Innovation Channel

Recently, the National Medical Products Administration’s Device Review Center released the results of the special review application for innovative medical devices (No. 2 of 2025), intending to approve 9 medical devices to enter the innovation channel. 1. Peripheral arterial stent graft system: Jiangsu Pupeng Medical Technology Co., Ltd Pupeng Medical was established on December 16, 2019, and is a subsidiary of Jiangsu Zhenyi Medical Technology Co., Ltd. (hereinafter referred to as Zhenyi Medical). It is reported that Zhenyi Medical focuses on the cardiovascular disease field with extremely high mortality and disability rates, and the domestic market is still blank. Its business comprehensively covers multiple interventional treatment fields such as heart valves, peripheral and coronary arteries. It is the first platform enterprise to achieve one-stop innovative solutions for blood flow management on a global scale. In addition to the products that entered the innovation channel this time, Park Peng Medical also ...
- Source: drugdu
- 38
- February 26, 2025
【EXPERT Q&A】Is CE certification required for EU GPSR compliance? What are the conditions?

Drugdu.com expert’s response: The Relationship Between EU GPSR Compliance and CE Certification Mandatory Compliance with GPSR: GPSR (General Product Safety Regulation) is a regulation of the European Union aimed at ensuring that products sold on the market are safe and do not pose a harm to consumers. Compliance with GPSR regulations is mandatory for most products. Definition and Scope of CE Certification: CE certification is a product compliance mark indicating that a product meets the safety, health, and environmental protection requirements of the European Union. It primarily applies to certain specific categories of products, such as electronics and machinery. Relationship Between GPSR and CE Certification: GPSR compliance and CE certification are two different compliance systems, but they overlap in some aspects. The directives and standards upon which CE certification is based correspond to the safety requirements of GPSR, but their focuses and scopes of application differ. Not all products that need to ...
- Source: drugdu
- 42
- February 26, 2025
CMEF

Organiser：Reed Sinopharm Exhibitions Time：April 8th – 11th, 2025 Address：Shanghai National Convention and Exhibition Center Address: No. 333 Songze Avenue, Xujing Town, Qingpu District, Shanghai Exhibition hall：Shanghai National Convention and Exhibition Center Product range: Medical Imaging Area: Radiological products, ultrasound products, nuclear medicine products, molecular imaging, interventional products, etc. Operating Room Area: Hybrid operating rooms, integrated operating room solutions, surgical instruments, anesthesia machines, ventilators, monitors, operating room engineering, surgical lights, ceiling-mounted equipment booms, etc. In Vitro Diagnostics Area: Comprehensive laboratory solutions, clinical diagnostic equipment, diagnostic reagents, POCT (point-of-care testing), household diagnostic devices, etc. Rehabilitation and Physiotherapy Area: Rehabilitation equipment, assistive devices, traditional Chinese medicine treatments, physiotherapy equipment, medical high-frequency devices, etc. Orthopedics Zone: Orthopedic implants for joints, trauma, and spine; orthopedic surgical instruments and equipment; bone power tools, and other orthopedic-related products. Medical Informatization Area: System integrators, mobile healthcare, medical management, quality control, clinical hospital information management systems, IT equipment ...
- Source: drugdu
- 46
- February 25, 2025

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.